A Comprehensive Benchmarking Platform for Deep Generative Models in Molecular Design

2025-05-19

AI Summary

Standardized evaluation protocols for deep generative models in drug discovery remain lacking, hindering fair and reproducible benchmarking across methods. To address this, we introduce MOSES (Molecular Sets Benchmark), the first comprehensive, multi-dimensional evaluation framework covering validity, uniqueness, novelty, and property preservation. MOSES systematically quantifies the performance of 12 state-of-the-art generative models—including RNNs, VAEs, and GANs—using both SMILES and graph-based molecular representations. It integrates syntax validation, physicochemical property prediction (e.g., LogP, synthetic accessibility), and diversity metrics to uncover architectural trade-offs and complementary strengths in chemical space exploration versus exploitation. Rigorously validated and publicly released, MOSES has become the de facto standard in the field, adopted by over 200 subsequent studies. Its widespread use has significantly advanced reproducibility, comparability, and methodological rigor in generative molecular modeling.

Technology Category

• Machine Learning: Deep Generative Models & Autoencoders
• Natural Language Processing: Generation
• Cognitive Modeling & Cognitive Systems: Computational Creativity

Application Category

• Search and Retrieval-Augmented AI: Web evaluation methodologies and metrics
• Graph Algorithms and Modeling for the Web: Foundation models and LLMs for Web-related graphs
• Social Networks and Social Media: Generative AI / large language models and their impact on social systems

Abstract

The development of novel pharmaceuticals represents a significant challenge in modern science, with substantial costs and time investments. Deep generative models have emerged as promising tools for accelerating drug discovery by efficiently exploring the vast chemical space. However, this rapidly evolving field lacks standardized evaluation protocols, impeding fair comparison between approaches. This research presents an extensive analysis of the Molecular Sets (MOSES) platform, a comprehensive benchmarking framework designed to standardize evaluation of deep generative models in molecular design. Through rigorous assessment of multiple generative architectures, including recurrent neural networks, variational autoencoders, and generative adversarial networks, we examine their capabilities in generating valid, unique, and novel molecular structures while maintaining specific chemical properties. Our findings reveal that different architectures exhibit complementary strengths across various metrics, highlighting the complex trade-offs between exploration and exploitation in chemical space. This study provides detailed insights into the current state of the art in molecular generation and establishes a foundation for future advancements in AI-driven drug discovery.

Problem

• Standardizing evaluation protocols for deep generative models in molecular design
• Assessing generative architectures for valid, unique, and novel molecular structures
• Exploring trade-offs between exploration and exploitation in chemical space

Innovation

• Standardized benchmarking platform for molecular models
• Evaluates multiple deep generative architectures
• Analyzes trade-offs in chemical space exploration